Smoking Status shows no Impact on the Treatment Response with Adalimumab in Patients with Hidradenitis suppurativa - Results from the German Hidradenitis Suppurativa Registry HSBest

被引:0
|
作者
Kirsten, Natalia [1 ]
Ohm, Frenz [1 ]
Gehrdau, Kathrin [1 ]
Stephan, Brigitte [2 ]
Ben-Anaya, Nesrine [2 ]
Pinter, Andreas [3 ]
Bechara, Falk [4 ]
Presser, Dagmar [5 ]
Zouboulis, Christos [6 ]
Podda, Maurizio [7 ]
Augustin, Matthias [1 ]
机构
[1] Inst Versorgungsforsch Dermatol & bei Pflegeberuf, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Inst Versorgungsforsch Dermatol & bei Pfelegeberu, Hamburg, Germany
[3] Univ Klinikum Frankfurt, Klin Dermatol Venerol & Allergol, Frankfurt, Germany
[4] Ruhr Univ Bochum, Klin Dermatol Venerol & Allergol, Bochum, Germany
[5] Univ Wurzburg UKW, Klin Dermatol Venerolo & Allergol, Wurzburg, Germany
[6] Med Hsch Brandenburg Theodor Fontane, Hsch klin Dermatol Venerol & Allergol, Dessau, Germany
[7] Klinikum Darmstadt, Klin Dermatol, Darmstadt, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P186
引用
收藏
页码:114 / 115
页数:2
相关论文
共 50 条
  • [21] Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa
    Cao, Yonghao
    Hong, Feng
    Conlon, Donna
    Sidur, Lauren
    Smith, Kathleen
    Fang, Yuni
    Cuff, Carolyn
    Kaymakcalan, Zehra
    Ruzek, Melanie
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 24 - 24
  • [22] Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa
    Cao, Y.
    Hong, F.
    Conlon, D. M.
    Sidur, L.
    Smith, K. M.
    Fang, Y.
    Cuff, C. A.
    Kaymakcalan, Z.
    Ruzek, M. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (04) : 804 - 814
  • [23] Adalimumab long-term treatment in hidradenitis suppurativa patients
    Rosi, Elia
    Di Cesare, Antonella
    Fastame, Maria T.
    Scandagli, Ilaria
    Silvi, Gianmarco
    Prignano, Francesca
    EXPERIMENTAL DERMATOLOGY, 2022, 31 : 104 - 104
  • [24] HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF HIDRADENITIS SUPPURATIVA IN GERMAN PATIENTS WITH HIDRADENITIS SUPPURATIVA
    Bechara, F. G.
    Tran, T.
    Ploug, U.
    Kiri, S.
    Bley, R.
    Grellmann, C.
    Melnik, S.
    VALUE IN HEALTH, 2023, 26 (12) : S101 - S101
  • [25] Validation of the hidradenitis suppurativa clinical response as a clinical endpoint for hidradenitis suppurativa treatment evaluation
    Okun, Martin
    Yang, Min
    Sundaram, Murali
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB68 - AB68
  • [26] Periodontal status in patients with hidradenitis suppurativa
    Jastrzab, Beata
    Pasnik-Chwalik, Barbara
    Konopka, Tomasz
    Krajewski, Piotr K.
    Szepietowski, Jacek C.
    Matusiak, Lukasz
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 71 - 71
  • [27] Impact of carriage of Staphylococcus aureus in response to adalimumab in hidradenitis suppurativa (HS)
    Stergianou, Dimitra
    Tzanetakou, Vassiliki
    Argyropoulou, Maria
    Kanni, Theodora
    Giamarellos-Bourboulis, Evangelos J.
    EXPERIMENTAL DERMATOLOGY, 2020, 29 : 55 - 55
  • [28] Hidradenitis suppurativa: Response to treatment with infliximab
    Lee, CT
    Dempsey, J
    Miller, J
    King, L
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P43 - P43
  • [29] Demyelinating disease complicating adalimumab treatment of hidradenitis suppurativa
    Wang, Etienne
    Sen, Priya
    Umapathi, Thirugnanam
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB138 - AB138
  • [30] Treatment of Hidradenitis Suppurativa Patient with Klinefelter Syndrome by Adalimumab
    Shin, Ji Yeoun
    Hong, Jung Yeon
    Lee, Ho Jung
    Sim, Chang Yoon
    Park, Young Lip
    Lee, Jong Suk
    Lee, Sung Yul
    Kim, Jung Eun
    ANNALS OF DERMATOLOGY, 2019, 31 (04) : 446 - 449